Table 3.
Factor | Participants, No./Total (%)a | Univariable Analysis | Multivariable Analysis | ||
---|---|---|---|---|---|
HR (95% CI) | P Value | aHR (95% CI)b | P Value | ||
HIV status | |||||
HIV negative | 35/326 (10.7) | Reference | .62 | Reference | .41 |
HIV positive | 29/241 (12.0) | 1.14 (.69–1.86) | 1.23 (.75–2.03) | ||
Agec | |||||
53–59 y | 39/246 (15.9) | 3.69 (1.32–10.32) | .01 | 3.61 (1.25–10.40) | .02 |
60–64 y | 16/143 (11.2) | 2.58 (.86–7.69) | 2.57 (.84–7.87) | ||
65–69 y | 5/95 (5.3) | 1.19 (.32–4.42) | 1.16 (.31–4.33) | ||
≥70 y | 4/83 (4.8) | Reference | Reference | ||
Ethnic origin | |||||
White | 57/538 (10.6%) | Reference | .008 | Reference | .02 |
African | 6/20 (30.0%) | 3.71 (1.63–8.45) | 3.11 (1.40–6.90) | ||
Asian | 1/9 (11.1%) | 1.06 (.16–7.10) | 1.76 (.29–10.60) |
Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval; HIV, human immunodeficiency virus; HR, hazard ratio.
Number and percentage of participants with incident infection per total amount of participants for each variable category.
aHRs are adjusted for HIV status, age, ethnic origin, and body mass index.
Age at time of severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody test.